Stay clear of or Use Alternate Drug. Coadministration of apalutamide, a powerful CYP3A4 inducer, with medicines that are CYP3A4 substrates may result in decrease exposure to these drugs. Avoid or substitute A further drug for these medicines when attainable. Assess for loss of therapeutic result if medication must be coadministered. Change dose In